Related references
Note: Only part of the references are listed.Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease
Katherine E. Olson et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia
Chandrani Sarkar et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives
Marco Cosentino et al.
Frontiers in Cellular Neuroscience (2015)
Expression of Dopaminergic Receptors on Human CD4+T Lymphocytes: Flow Cytometric Analysis of Naive and Memory Subsets and Relevance for the Neuroimmunology of Neurodegenerative Disease
Natasa Kustrimovic et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2014)
Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines
Chandrani Sarkar et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?
Marco Cosentino et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
The First Insubria Autumn School on Neuroimmunopharmacology: Challenging Paradigms Beyond Boundaries
Marco Cosentino et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Neural and Immune Mechanisms in the Pathogenesis of Parkinson's Disease
Fabio Blandini
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Lessons from 60 years of pharmaceutical innovation
Bernard Munos
NATURE REVIEWS DRUG DISCOVERY (2009)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Share Paper
